No Data
No Data
Sichuan Hebang Biotechnology (603077.SH): has actually repurchased 0.70% of the company's shares.
Gelonghui November 1st | sichuan hebang biotechnology (603077.SH) announced that on November 1, 2024, the company completed this repurchase. This time, a total of 62,181,660 shares were repurchased, accounting for 0.70% of the company's total share capital. The highest repurchase price was 1.72 yuan/share, the lowest repurchase price was 1.64 yuan/share, the average repurchase price was 1.67 yuan/share, and the total amount of funds used was 103,995,776.75 yuan.
Hebang Biotech: Hebang Biotech Report for the Third Quarter of 2024
Hebang Biotech Announces Major Operating Data for January-September 2024
Hebang Biotech Report for the Third Quarter of 2024
Sichuan Hebang Biotechnology (603077.SH): The net income in the first three quarters was 0.221 billion yuan, a decrease of 78.28% year-on-year.
GeLong Hui, October 30th | Sichuan Hebang Biotechnology (603077.SH) announced that in the first three quarters of 2024, it achieved revenue of 6.814 billion yuan, an increase of 5.89% year-on-year; net income attributable to the shareholders of the listed company was 0.221 billion yuan, a decrease of 78.28% year-on-year, with basic earnings per share of 0.0268 yuan.
Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Price Is Right But Growth Is Lacking
Sichuan Hebang Biotechnology (SHSE:603077) Has Some Way To Go To Become A Multi-BaggerNo Data
No Data
